Scalper1 News
Halozyme Therapeutics has been one of 2015’s hotter biotech stocks, but it’s not exactly because of developing a drug. Halozyme’s (HALO) one marketed product, Hylenex, aids in the delivery of injectable drugs. Halozyme has also licensed Enhanz for the same purpose to such drug companies as Pfizer (PFE), Roche (RHHBY), Johnson & Johnson ‘s (JNJ) Janssen division, AbbVie (ABBV) and Baxalta (BXLT) for the development of new injectable products. San Scalper1 News
Scalper1 News